ArticleCancer biology & therapy2016
p.(L576P) -KIT mutation in GIST: Favorable prognosis and sensitive to imatinib?
Jonathan Noujaim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleCancer biology & therapy2016
Jonathan Noujaim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.